These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations]. De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184 [TBL] [Abstract][Full Text] [Related]
7. Crescentic lupus glomerulonephritis. Yeung CK; Wong KL; Wong WS; Ng MT; Chan KW; Ng WL Clin Nephrol; 1984 May; 21(5):251-8. PubMed ID: 6733993 [TBL] [Abstract][Full Text] [Related]
8. [Nephropathy associated with systemic lupus erythematosus]. Szabó J; Szabó T; Lustyik G; Kakuk G; Locsey L; Szegedi G; Szegedi J; Sonkoly I Morphol Igazsagugyi Orv Sz; 1977 Apr; 17(2):81-9. PubMed ID: 876263 [TBL] [Abstract][Full Text] [Related]
9. Plasma exchange and immunosuppressive therapy in a paediatric patient with systemic lupus erythematosus. Túri S; Haszon I; Bodrogi T Acta Paediatr Hung; 1988-1989; 29(3-4):293-8. PubMed ID: 3151982 [TBL] [Abstract][Full Text] [Related]
10. Nephrotic syndrome: a clinico-pathological study. Johan A; Tan KK Singapore Med J; 1972 Feb; 13(1):14-23. PubMed ID: 5031949 [No Abstract] [Full Text] [Related]
11. [What is achieved by therapy of the nephrotic syndrome in adults?]. Thiel G; Koelz A; Brunner FP Internist (Berl); 1976 Dec; 17(12):612-21. PubMed ID: 795782 [No Abstract] [Full Text] [Related]
13. [Nature of proteinuria and the effectiveness of immunosuppressive therapy in children with lupus nephritis]. Popkova GK; Belokrinitskii DV; Ostrovskaia AI Pediatriia; 1975 Sep; (9):38-41. PubMed ID: 1219598 [No Abstract] [Full Text] [Related]
14. [Heparin treatment of rheumatoid arthritis and systemic lupus erythematosus]. Murav'ev IuV; Samoĭlova SI Ter Arkh; 1979; 51(7):48-52. PubMed ID: 494087 [No Abstract] [Full Text] [Related]
15. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. Tanaka E; Harigai M; Tanaka M; Kawaguchi Y; Hara M; Kamatani N J Rheumatol; 2002 Feb; 29(2):282-7. PubMed ID: 11838845 [TBL] [Abstract][Full Text] [Related]
16. [Significance of the tubulointerstitial and fibroplastic components of nephritis for the prognosis of kidney lesions in systemic lupus erythematosus]. Demin AA; Semenova LA; Sentiakova TN; Poliachenko EA; Smirnov VV Urol Nefrol (Mosk); 1986; (1):28-31. PubMed ID: 3952899 [No Abstract] [Full Text] [Related]
17. [Association of systemic lupus erythematosus and dermatopolymyositis]. Kilani B; Amari L; Houmane H; Ben Châabane T Tunis Med; 2005 Apr; 83(4):230-2. PubMed ID: 15966670 [TBL] [Abstract][Full Text] [Related]